Stimulation of mitochondrial fatty acid oxidation by growth hormone in human fibroblasts

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4208-4213

  Leung, Kin Chuen ^a   Ho, Ken K Y ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; MONOCLONAL ANTIBODY; PALMITIC ACID; SOMATOMEDIN C;

ANTIBODY SPECIFICITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; FATTY ACID OXIDATION; FIBROBLAST CULTURE; HORMONE ACTION; HUMAN; HUMAN CELL; LIPID METABOLISM; MITOCHONDRION; PRIORITY JOURNAL;

EID: 0030781732     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.12.4208     Document Type: Article

References (42)

1. Davidson MB. 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 8:115-131.
2. Dietz J, Schwartz J. 1991 Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes. Metabolism. 40:800-806.
3. Slavin BG, Ong JM, Kern PA. 1991 Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 35:1535-1541.
4. Hoogerbrugge N, Jansen H, Staels B, Seip MJE, Birkenhager JC. 1993 Growth hormone normalizes hepatic lipase in hypothyroid rat liver. Metabolism. 42:669-671.
5. Parini P, Angelin B, Lobie PE, Norstedt G, Rudling M. 1995 Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology. 136:3767-3773.
6. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson J-A, Angelin B. 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 89:6983-6987.
7. Vikman-Adolfsson K, Oscarsson J, Nilsson-Ehle P, Eden S. 1994 Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized rats. J Endocrinol. 140:203-209.
8. Møller N, Jørgensen JOL, Alberti KGMM, Flyvbjerg A, Schmitz O. 1990 Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab. 70:1179-1186.
9. Møller J, Jørgensen JOL, Møller N, Christiansen JS, Weeke J. 1992 Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism. 41:728-731.
10. Møller N, Porksen N, Ovesen P, Alberti KGMM. 1993 Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans. Horm Metab Res. 25:175-179.
11. Mjaaland M, Unneberg K, Bjøro T, Revhaug A. 1993 Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition. Metabolism. 42:185-190.
12. Schulz H. 1991 Beta oxidation of fatty acids. Biochim Biophy Acta. 1081:109-120.
13. Rhead WJ. 1990 Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview. In: Tanaka K, Coates PM, eds. Fatty acid oxidation: clinical, biochemical, and molecular aspects. New York: Alan R. Liss, Inc; 365-382.
14. 14C]fatty acid oxidation. Biochem Med Metab Biol. 35:248-259.
15. Moon A, Rhead WJ, 1987 Complementation analysis of fatty acid oxidation orders. J Clin Invest. 79:59-64.
16. Murphy LJ, Vrhovsek E, Lazarus L. 1983 Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. J Clin Endocrinol Metab. 57:1117-1124.
17. Oakes SR, Haynes KM, Waters MJ, Herington AC, Werther GA. 1992 Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab. 75:1368-1373.
18. Clemmons DR, Underwood LE, Van Wyk JJ. 1981 Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts. J Clin Invest. 67:10-19.
19. Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. 1989 The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf). 30:335-345.
20. Barnard R, Bundesen PG, Rylatt DB, Waters MJ. 1984 Monoclonal antibodies to the rabbit liver growth hormone receptor: production and characterization. Endocrinology. 115:1805-1813.
21. Barnard R, Bundesen PG, Rylatt DB, Waters MJ. 1985 Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J. 231:459-468.
22. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:537-543.
23. Goldschmidt RC, Kimelberg HK. 1989 Protein analysis of mammalian cells in monolayer culture using the bicinchoninic assay. Anal Biochem. 177:41-45.
24. Leung K-C, Rajkovic IA, Peters E, Markus I, Van Wyk JJ, Ho KKY. 1996 Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action. Endocrinology. 137:2694-2702.
25. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. 1992 Rational design of potent antagonists to the human growth hormone receptor. Science. 256:1677-1680.
26. Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 254:821-825.
27. Reutens AT, Hoffman DM, Leung K-C, Ho KKY. 1995 Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. J Clin Endocrinol Metab. 80:480-485.
28. Grichting G, Levy LK, Goodman HM. 1983 Relationship between binding and biological effects of human growth hormone in rat adipocytes. Endocrinology. 113:1111-1120.
29. Goodman HM. 1984 Biological activity of bacterial derived human growth hormone in adipose tissue of hypophysectomized rats. Endocrinology. 114:131-135.
30. Van Vliet G, Bosson D, Craen M, Du Caju MVL, Malvaux P, Vanderschueren-Lodeweyckx M. 1987 Comparative study of the lipolytic potencies of pituitary-derived and biosynthetic human growth hormone in hypopituitary children. J Clin Endocrinol Metab. 65:876-879.
31. Lim L, Spencer SA, McKay P, Waters MJ. 1990 Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology. 127:1287-1291.
32. Mannor DA, Winer LM, Shaw MA, Baumann G. 1991 Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action. J Clin Endocrinol Metab. 73:30-34.
33. Carter-Su C, Schwartz J, Smit LS. 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol. 58:187-207.
34. Murphy LJ, Lazarus L. 1984 The mouse fibroblast growth hormone receptor: ligand processing and receptor modulation and turnover. Endocrinology. 115:1625-1632.
35. Roupas P, Herington AC. 1989 Cellular mechanisms in the processing of growth hormone and its receptor. Mol Cell Endocrinol. 61:1-12.
36. Grunnet N, Kondrup J. 1986 The effect of ethanol on the beta-oxidation of fatty acids. Alcohol Clin Exp Res. 10:64S-68S.
37. Latipaa PM, Karki TT, Hiltunen JK, Hassinen IE. 1986 Regulation of palmitoylcarnitine oxidation in isolated rat liver mitochondria. Role of the redox state of NAD(H). Biochim Biophy Acta. 875:293-300.
38. Hussain MA, Schmitz O, Mengel A, et al. 1993 Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest. 92:2249-2256.
39. Hussain MA, Schmitz O, Mengel A, et al. 1994 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest. 94:1126-1133.
40. Kaikaus RM, Bass NM, Ockner RK. 1990 Functions of fatty acid binding proteins. Experientia. 46:617-630.
41. Berry SA, Yoon J-B, List J, Seelig S. 1993 Hepatic fatty acid-binding protein mRNA is regulated by growth hormone. J Am Coll Nutr. 12:638-642.
42. Willi SM, Zhang Y, Key Jr LL, Kelly DP. Growth hormone stimulates the expression of enzymes in hepatic fatty acid metabolism. Proc of the 77th Annual Meeting of The Endocrine Society, Washington, DC, 1995, p 347.